Enlivex Therapeutics Ltd. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Enlivex Therapeutics Ltd. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q2 2024.
  • Enlivex Therapeutics Ltd. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $870K, a 81.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $870K -$3.86M -81.6% Jun 30, 2024 6-K 2024-08-30
Q4 2023 $1.04M -$3.98M -79.3% Dec 31, 2023 6-K 2024-08-30
Q2 2023 $4.73M -$635K -11.8% Jun 30, 2023 6-K 2023-09-01
Q4 2022 $5.03M -$664K -11.7% Dec 31, 2022 20-F 2024-04-30
Q2 2022 $5.37M +$4.8M +840% Jun 30, 2022 6-K 2022-08-22
Q4 2021 $5.69M +$5.03M +763% Dec 31, 2021 6-K 2022-08-22
Q2 2021 $571K Jun 30, 2021 6-K 2021-08-06
Q4 2020 $659K +$249K +60.7% Dec 31, 2020 6-K 2021-08-06
Q4 2019 $410K Dec 31, 2019 20-F 2021-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.